Atlanta, GA
The Westin Buckhead
May 1,  2026
5.5 CME/CPE/CE & ABPath MOC Available

Advancing Precision Cancer Care

Atlanta, GA
May 1, 2026

Advancing the Diagnostic-to-Treatment Continuum in Cancer Care –
Atlanta

Advancing precision medicine across the Southeast

Atlanta stands at the crossroads of innovation and patient-centered cancer care. The Advancing Pathology Education (APE) and Advancing Precision Oncology (APO) regional program brings together leading experts from across the Southeast to explore how biomarker-driven diagnostics, molecular profiling, and targeted therapeutics are transforming oncology practice.

This complimentary educational program is presented in partnership with City of Hope Cancer Center Atlanta and will be chaired by Debora Bruno, MD, MS, thoracic medical oncologist and Medical Director of Clinical Research at City of Hope Atlanta. Dr. Bruno is a recognized leader in thoracic oncology and clinical research, specializing in the treatment of lung cancer and related thoracic malignancies while overseeing the expansion of innovative clinical trials at City of Hope.

Under Dr. Bruno’s leadership, the program will highlight the rapidly evolving role of precision medicine in cancer care—bringing together oncologists, pathologists, and multidisciplinary specialists to discuss practical strategies for integrating biomarker-guided diagnostics and targeted therapies into clinical practice.

This free, CME-accredited meeting unites pathology and oncology professionals from across hospital systems and academic centers to strengthen collaboration and accelerate the adoption of precision oncology—ensuring that every patient benefits from the latest advances in cancer research and treatment.

Agenda

Event Partner

May 1, 2026
8:00 AMRegistration & Check-in
8:55 AMWelcome and Introductions Debora Bruno, MD, MS, City of Hope, Nigel Russell, APE|APO 
9:00 AMBreast Cancer: Biomarkers & Methodologies Sunil Badve, MD, FRCPath, Emory University School of Medicine
9:30 AMBreast Cancer Keerthi Gogineni, MD, MSHP, Emory University School of Medicine
10:00 AMExhibits/Breakfast
10:30 AMElacestrant Real-World Data in Patients with HR+/HER2- Advanced Breast Cancer – Non-CME Session  Eric Kruep, PharmD, MS, Menarini Stemline 
11:00 AMExhibits/Networking
11:30 AMLung Cancer Debora Bruno, MD, MS, City of Hope 
12:00 PMLung Cancer: Biomarkers & Methodologies  Navid Sadri, MD, PhD, University Hospitals Health System
12:30 PMColorectal Cancer: Biomarkers & Methodologies Stanley Hamilton, MD, FCAP, AGAF, City of Hope
1:00 PMLunch/Exhibits
1:30 PMThe Value of Molecular Testing – Improving Clinical Outcomes with Precision Oncology – Non-CME Session  Samuel Caughron, MD, MAWD Pathology Group 
2:15 PMExhibits/Break
2:45 PMProstate Cancer Biomarkers: From PSA to Precision Medicine Bamidele A. Adesunloye, MD, MS, FACP, City of Hope 
3:15 PMTranslational Prostate Cancer Solutions to Improve Health Outcomes for High-Risk Populations Leanne Woods-Burnham, PhD, Morehouse School of Medicine
3:45 PMNovel Therapies in Acute Leukemias Lizamarie Bachier-Rodriguez, MD, Northside Hospital
4:15 PMMRD in Myeloma: Prime Time or Premature? Sabarish Ram Ayyappan, MD, City of Hope
4:45 PMExhibits/Break
5:00 PMTargeted Therapies in Lung Cancer Panel Discussion Priya Rudolph, MD, PHD, Northside Hospital Cancer Institute; Chandar Bhimani, MD, Northwest Georgia Oncology Centers Wellstar; Nitika Sharma, MD, City of Hope; Zane Ken Wade, MD, St. Mary’s Healthcare System
6:00 PMAdjourn

  • Integrate evidence-based advances from both pathology and oncology to enhance biomarker testing, diagnosis, and treatment planning for solid tumors and hematologic malignancies.

  • Apply multidisciplinary insights and new clinical data to improve therapeutic decision-making and patient outcomes across diverse practice settings.

Download Information Here!

Speakers

CHAIR

Debora Bruno, MD, MS

Medical Director, Clinical Research
Thoracic Medical Oncologist
City of Hope Cancer Center Atlanta

Bamidele A. Adesunloye, MD, MS, FACP

Medical Oncologist
Chief, Medical Oncology
City of Hope Cancer Center Atlanta

Sabarish Ram Ayyappan, MD

Medical Director
Cellular Therapy
City of Hope Cancer Center Atlanta

Lizamarie Bachier-Rodriguez, MD

Hematologist-Oncologist
Bone Marrow Transplantation, Leukemia and Immunotherapy
Northside Hospital

Sunil Badve, MD, FRCPath

Vice Chair, Pathology Cancer Programs
Emory University School of Medicine
Winship Cancer Institute of Emory University

Chandar Bhimani, MD

Oncologist/Hematologist
Northwest Georgia Oncology Centers

Sam Caughron, MD

President & CEO
MAWD Pathology Group

Keerthi Gogineni, MD MSHP

Associate Professor
Department of Hematology and Medical Oncology
Emory University School of Medicine

Stanley Hamilton, MD, FCAP, AGAF

Adjunct Professor
Department of Pathology
University of Texas MD Anderson Cancer Center

Eric Kruep, PharmD, MS

Executive Director
Clinical & Value Evidence Liaison (CVEL) Team
Menarini Stemline

Priya Rudolph, MD, PhD

Medical Oncologist and Hematologist
Northside Hospital Cancer Institute

Navid Sadri, MD, PhD

Chief
Division of Genomic and Molecular Pathology
University Hospitals Health System

Nitika Sharma, MD

Medical Oncologist
City of Hope Cancer Center

Zane Ken Wade, MD

Pathologist
St. Mary’s Health Care System

Leanne Woods-Burnham, PhD

Assistant Professor
Department of Surgery
Morehouse School of Medicine

THE LOCATION

The Westin Buckhead

3391 Peachtree Road, NE

Atlanta, GA 30326

 

Atlanta

REGISTRATION OPEN

SPONSOR

Interested in sponsoring the event? Email Gary King by using the link below!

Sponsor